全部版块 我的主页
论坛 新商科论坛 四区(原工商管理论坛) 行业分析报告
3760 6
2008-03-31

Contents
INTRODUCTION.........................................................................................................1
Report Coverage ....................................................................................................................................................1
Executive Summary ..............................................................................................................................................4
Other Access Asia Reports of Possible Interest..............................................................................................5
Glossary....................................................................................................................................................................6
Free Online Newsletter and Editorials..............................................................................................................8
1 CHINA’S OTC PHARMACEUTICALS MARKET ..............................................9
1.1 Overview............................................................................................................................................................9
1.2 China’s Total Non-food Market...................................................................................................................9
1.2.1 Total Non-food Market: Food and Non-food Sales .............................................................................9
Table 1.1 TOTAL CURRENT VALUE RETAIL SALES BY FOOD AND NON-FOOD,
1999-2005 ..........................................................................................................................................................9
1.2.2 Total Non-food Market: Food/Non-food Sales Split .........................................................................10
Table 1.2 % BREAKDOWN OF RETAIL SALES BY FOOD AND NON-FOOD, 1999-2005..
.......................................................................................................................................................10
1.2.3 Total Non-food Market: Urban and Rural Split .................................................................................10
Table 1.3 TOTAL CURRENT VALUE RETAIL SALES BY FOOD AND NON-FOOD,
1999-2005 .......................................................................................................................................................11
1.2.4 Total Non-food Market: Total Value Trends......................................................................................11
Table 1.4 CURRENT VALUE OF TOTAL RETAIL NON-FOOD SALES BY MAJOR
PRODUCT CATEGORY, 1999-2005............................................................................................................12
1.2.5 Total Non-food Market: Urban Value Trends....................................................................................12
Table 1.5 URBAN RETAIL NON-FOOD SALES CURRENT VALUE BY MAJOR
PRODUCT CATEGORY, 1999-2005............................................................................................................13
1.2.6 Total Non-food Market: Rural Value Trends......................................................................................13
Table 1.6 VALUE OF RURAL RETAIL NON-FOOD SALES CURRENT VALUE BY
MAJOR PRODUCT CATEGORY, 1999-2005...........................................................................................14
1.3 China’s Total Pharmaceuticals Market Size.........................................................................................15
1.3.1 Total Market Size: Overall Pharmaceuticals Market Size ................................................................15
Table 1.7 ALL PHARMACEUTICALS PRODUCTION IN CHINA BY BROAD SECTOR,
1998-2005 .......................................................................................................................................................15
1.3.2 Total Market Size: Prepared Pharmaceuticals Total Market Size ...................................................15
Table 1.8 PREPARED PHARMACEUTICALS EXPENDITURE IN CHINA BY BROAD
SECTOR, 1998-2005..........................................................................................................................................16
1.3.3 Total Market Size: Prepared Pharmaceuticals Wholesale Market Size ..........................................16

Table 1.9 PREPARED PHARMACEUTICALS WHOLESALE TRADE IN CHINA BY
BROAD SECTOR, 1998-2005..........................................................................................................................16
1.3.4 Total Market Size: Prepared Pharmaceuticals Retail Market Size ..................................................16
Table 1.10 PREPARED PHARMACEUTICALS RETIL SALES IN CHINA BY BROAD
SECTOR, 1998-2005..........................................................................................................................................16
1.4 China’s OTC Pharmaceuticals Market Size .........................................................................................17
1.4.1 OTC Pharmaceuticals Market: Overview............................................................................................17
1.4.2 OTC Pharmaceuticals Market: Total OTC Market Size ...................................................................18
Table 1.11 TOTAL MARKET FOR OTC PHARMACEUTICALS IN CHINA, 1998-2005....19
1.4.3 OTC Pharmaceuticals Market: Non-food Market Significance.......................................................20
Table 1.12 THE TOTAL OTC PHARMACEUTICALS MARKET AS A PROPORTION OF
TOTAL NON-FOOD RETAIL SALES IN CHINA, 1998-2005.............................................................20
1.4.4 OTC Pharmaceuticals Market: Urban Vs Rural Sales.......................................................................21
Table 1.13 URBAN VS RURAL SALES OF OTC PHARMACEUTICALS IN CHINA, 1998-
2005 .......................................................................................................................................................21
1.5 Regional Markets .........................................................................................................................................22
1.5.1 Regional Markets: Provincial Values...................................................................................................22
Table 1.14 VALUE OF OTC PHARMACEUTICALS RETAIL MARKET BY PROVINCE
IN CHINA, 1999-2005.......................................................................................................................................22
1.5.2 Regional Markets: Value Market Growth & Breakdown .................................................................23
Table 1.15 % BREAKDOWN & MARKET VALUE GROWTH OF OTC
PHARMACEUTICALS RETAIL MARKET BY PROVINCE IN CHINA, 1999-2005..................23
1.5.3 Regional Markets: Per Capita Spending..............................................................................................24
Table 1.16 PER CAPITA RETAIL SPENDING ON OTC PHARMACEUTICALS BY
PROVINCE IN CHINA, 1999-2005...............................................................................................................24
1.6 OTC Sector Breakdown ..............................................................................................................................25
1.6.1 Sector Breakdown: Sector Values.........................................................................................................25
Table 1.17 VALUE SALES OF OTC PHARMACEUTICALS BY SECTOR IN CHINA, 1998-
2005 .......................................................................................................................................................25
1.6.2 Sector Breakdown: Sector Shares .........................................................................................................26
Table 1.18 % BREAKDOWN OF OTC PHARMACEUTICALS VALUE SALES BY
SECTOR IN CHINA, 1998-2005.....................................................................................................................26
1.6.3 Sector Breakdown: Growth Rates.........................................................................................................26
Table 1.19 % ANNUAL GROWTH FOR VALUE SALES OF OTC PHARMACEUTICALS
BY SECTOR IN CHINA, 1998-2005..............................................................................................................26
1.7 Analgesics .......................................................................................................................................................27
1.7.1 Analgesics: Subsector Values................................................................................................................27
Table 1.20 MARKET VALUE SALES OF ANALGESICS BY SUBSECTOR IN CHINA,
1998-2005 .......................................................................................................................................................27
1.7.2 Analgesics: Value Subsector Shares.....................................................................................................27
Table 1.21 % BREAKDOWN OF VALUE SALES OF ANALGES ICS BY SUBSECTOR IN
CHINA, 1998-2005.............................................................................................................................................27

1.7.3 Analgesics: Value Growth Rates ..........................................................................................................28
Table 1.22 % ANNUAL GROWTH FOR VALUE SALES OF ANALGESICS BY
SUBSECTOR IN CHINA, 1998-2005............................................................................................................28
1.8 Cough, Cold & Allergy Remedies.............................................................................................................28
1.8.1 Cough, Cold & Allergy Remedies: Subsector Values.......................................................................28
Table 1.23 MARKET VALUE SALES OF COUGH, COLD & ALLERGY REMEDIES BY
SUBSECTOR IN CHINA, 1998-2005............................................................................................................28
1.8.2 Cough, Co ld & Allergy Remedies: Value Subsector Shares ...........................................................29
Table 1.24 % BREAKDOWN OF VALUE SALES OF COUGH, COLD & ALLERGY
REMEDIES BY SUBSECTOR IN CHINA, 1998-2005............................................................................29
1.8.3 Cough, Cold & Allergy Remedies: Value Growth Rates .................................................................29
Table 1.25 % ANNUAL GROWTH FOR VALUE SALES OF COUGH, COLD & ALLERGY
REMEDIES BY SUBSECTOR IN CHINA, 1998-2005............................................................................29
1.9 Digestive Remedies ......................................................................................................................................30
1.9.1 Digestive Remedies: Subsector Values................................................................................................30
Table 1.26 MARKET VALUE SALES OF DIGESTIVE REMEDIES BY SUBSECTOR IN
CHINA, 1998-2005.............................................................................................................................................30
1.9.2 Digestive Remedies: Value Subsector Shares ....................................................................................30
Table 1.27 % BREAKDOWN OF VALUE SALES OF DIGESTIVE REMEDIES BY
SUBSECTOR IN CHINA, 1998-2005............................................................................................................30
1.9.3 Digestive Remedies: Value Growth Rates ..........................................................................................31
Table 1.28 % ANNUAL GROWTH FOR VALUE SALES OF DIGESTIVE REMEDIES BY
SUBSECTOR IN CHINA, 1998-2005............................................................................................................31
1.10 Medicated Skincare...................................................................................................................................32
1.10.1 Medicated Skincare: Subsector Values..............................................................................................32
Table 1.29 MARKET VALUE SALES OF MEDICATED SKINCARE BY SUBSECTOR IN
CHINA, 1998-2005.............................................................................................................................................32
1.10.2 Medicated Skincare: Value Subsector Shares ..................................................................................32
Table 1.30 % BREAKDOWN OF VALUE SALES OF MEDICATED SKINCARE BY
SUBSECTOR IN CHINA, 1998-2005............................................................................................................33
1.10.3 Medicated Skincare: Value Growth Rates ........................................................................................33
Table 1.31 % ANNUAL GROWTH FOR VALUE SALES OF MEDICATED SKINCARE BY
SUBSECTOR IN CHINA, 1998-2005............................................................................................................33
1.11 Vitamins & Dietary Supplements...........................................................................................................34
1.11.1 Vitamins & Dietary Supplements: Subsector Values......................................................................34
Table 1.32 MARKET VALUE SALES OF VITAMINS & DIETARY S UPPLEMENTS BY
SUBSECTOR IN CHINA, 1998-2005............................................................................................................34
1.11.2 Vitamins & Dietary Supplements: Value Subsector Shares ..........................................................35
Table 1.33 % BREAKDOWN OF VALUE SALES OF VITAMINS & DIETARY
SUPPLEMENTS BY SUBSECTOR IN CHINA, 1998-2005...................................................................35
1.11.3 Vitamins & Dietary Supplements: Value Growth Rates ................................................................36

Table 1.34 % ANNUAL GROWTH FOR VALUE SALES OF VITAMINS & DIETARY
SUPPLEMENTS BY SUBSECTOR IN CHINA, 1998-2005...................................................................36
1.12 Other OTC Products.................................................................................................................................37
1.12.1 Other OTC: Subsector Values .............................................................................................................37
Table 1.35 MARKET VALUE SALES OF OTHER OTC PRODUCTS BY SUBSECTOR IN
CHINA, 1998-2005.............................................................................................................................................37
1.12.2 Other OTC: Value Subsector Shares..................................................................................................37
Table 1.36 % BREAKDOWN OF VALUE SALES OF OTHER OTC BY SUBSECTOR IN
CHINA, 1998-2005.............................................................................................................................................37
1.12.3 Other OTC: Value Growth Rates........................................................................................................38
Table 1.37 % ANNUAL GROWTH FOR VALUE SALES OF OTHER OTC BY
SUBSECTOR IN CHINA, 1998-2005............................................................................................................38
1.13 Market Shares ............................................................................................................................................39
1.13.1 Market Shares: Western Medicine Manufacturer Shares ...............................................................39
Table 1.38 MANUFACTURERS’ SHARES OF RAW PHARMACEUTICAL CHEMICAL
INDUSTRY REVENUES IN CHINA, 2002/2003.......................................................................................39
Table 1.39 MANUFACTURERS’ SHARES OF PREPARED PHARMACEUTICAL
PRODUCTS INDUSTRY REVENUES IN CHINA, 2002/2003.............................................................40
1.13.2 Market Shares: Traditional Chinese Medicine Manufacturer Shares ...........................................40
Table 1.40 MANUFACTURERS’ SHARES OF TRADITIONAL CHINESE MEDICINE
PHARMACEUTICAL INDUSTRY REVENUES IN CHINA, 2002/2003..........................................40
1.13.3 Market Shares: Veterinary Medicine Manufacturer Shares ...........................................................41
Table 1.41 MANUFACTURERS’ SHARES OF VETERINARY PHARMACEUTICAL
INDUSTRY REVENUES IN CHINA, 2002/2003.......................................................................................41
1.14 Prices .............................................................................................................................................................42
1.14.1 Prices: Retail Price Indices ..................................................................................................................42
Table 1.42 RETAIL PRICE INDICES BY BROAD SECTOR, 1999-2005...................................42
1.15 Outlook .........................................................................................................................................................43
1.15.1 Outlook: Forecast Trends.....................................................................................................................43
1.15.2 Outlook: Forecast Total Market Size .................................................................................................43
Table 1.43 FORECAST ALL PHARMACEUTICALS PRODUCTION IN CHINA BY
BROAD SECTOR, 2006-2010..........................................................................................................................43
Table 1.44 FORECAST PREPARED PHARMACEUTICALS EXPENDITURE IN CHINA
BY BROAD SECTOR, 2006-2010..................................................................................................................44
Table 1.45 FORECAST PREPARED PHARMACEUTICALS WHOLESALE TRADE IN
CHINA BY BROAD SECTOR, 2006-2010..................................................................................................44
Table 1.46 FORECAST PREPARED PHARMACEUTICALS RETIL SALES IN CHINA BY
BROAD SECTOR, 2006-2010..........................................................................................................................44
1.15.3 Outlook: Forecast OTC Market Size ..................................................................................................44
Table 1.47 FORECAST TOTAL MARKET FOR OTC PHARMACEUTICALS IN CHINA,
2006-2010 .......................................................................................................................................................44

1.15.4 Outlook: Forecast Sector Values.........................................................................................................45
Table 1.48 FORECAST VALUE SALES OF OTC PHARMACEUTICALS BY SECTOR IN
CHINA, 2006-2010.............................................................................................................................................45
1.15.5 Outlook: Forecast Sector Percentages................................................................................................45
Table 1.49 FORECAST % BREAKDOWN OF OTC PHARMACEUTICALS VALUE SALES
BY SECTOR IN CHINA, 2006-2010..............................................................................................................46
1.15.6 Outlook: Forecast Sector Annual Growth Rates ..............................................................................46
Table 1.50 FORECAST % ANNUAL GROWTH OF OTC PHARMACEUTICALS VALUE
SALES BY SECTOR IN CHINA, 2006-2010..............................................................................................47
1.16 Current Issues.............................................................................................................................................48
1.16.1 Current Issues: Legislation Affecting China’s Pharmaceuticals Industry ...................................48
1.16.2 Current Issues: Definition of Medicines in China ...........................................................................50
1.16.3 Current Issues: Production of Pharmaceuticals in China................................................................51
1.16.4 Current Issues: Pharmaceuticals Licensing in China ......................................................................51
1.16.5 Current Issues: Pharmaceuticals Industrial Policy in China ..........................................................51
1.16.6 Current Issues: Pharmaceuticals Licensing in China ......................................................................52
1.16.7 Current Issues: Pharmaceuticals Packaging in China .....................................................................52
1.16.8 Current Issues: Regulatory Bodies for the Pharmaceutical Industry in China............................52
The Ministry of Public Health.................................................................................................................52
The State Pharmaceutical Administration (SPAC)..............................................................................52
2 MARKETING & DISTRIBUTION ....................................................................... 53
2.1 Marketing & Advertising...........................................................................................................................53
2.1.1 Marketing: Overview ..............................................................................................................................53
2.1.2 Marketing: Pharmaceutical Branding & Advertising........................................................................54
2.1.3 Marketing: Pharmaceutical Brand Introduction.................................................................................54
2.1.4 Marketing: New Opportunities and Latest Developments................................................................55
2.2 Consumers......................................................................................................................................................55
2.2.1 Consumer Profile: Broad Consumer Trends.......................................................................................55
2.2.2 Consumer Profile: OTC Consumers .....................................................................................................56
The Elderly ................................................................................................................................................57
Women .......................................................................................................................................................57
Children......................................................................................................................................................57
2.3 Wholesale Distribution...............................................................................................................................58
2.3.1 Wholesale Distribution: Overview.......................................................................................................58
2.3.2 Distribution: OTC Distribution .............................................................................................................58
2.3.3 The Main Distribution Companies........................................................................................................59
2.3.4 Trends in Retail Sales by Outlet............................................................................................................60
3 CHINA’S HEALTHCARE SERVICES............................................................... 61
3.1 Historical Overview.....................................................................................................................................61
3.2 China’s Healthcare Services: Public Healthcare Policy.....................................................................62
3.3 China’s Healthcare Services: Healthcare in Rural Areas..................................................................63

3.4 China’s Healthcare Services: Chinese Remedies .................................................................................63
3.5 China’s Healthcare Services: Administrative Agencies .....................................................................64
3.5.1 Administrative Agencies: State Food and Drug Administration of China (SFDA).....................64
3.5.2 Administrative Agencies: The State Development and Reform Commission..............................66
3.5.3 Administrative Agencies: The Ministry of Commerce .....................................................................66
3.5.4 Administrative Agencies: The Ministry of Labor and Social Security ..........................................66
3.5.5 Administrative Agencies: The Ministry of Health.............................................................................66
3.5.6 Administrative Agencies: The State Traditional Chinese Medicine Administration...................66
3.5.7 Administrative Agencies: The State Population and Family Planning Commission...................66
3.5.8 Administrative Agencies: The Ministry of Science and Technology.............................................66
3.5.9 Administrative Agencies: The State Quality Control Administration............................................66
3.5.10 Administrative Agencies: Industrial Associations...........................................................................66
4 SOURCES OF SUPPLY...................................................................................... 67
4.1 Domestic Medicine Research & Development ......................................................................................67
4.2 Total Pharmaceutical Industry Size ........................................................................................................68
4.2.1 Total Pharmaceutical Industry: Total Industry Manufacturers & Revenue...................................68
Table 4.1 TOTAL NUMBER OF PHARMACEUTICALS MANUFACTURERS AGAINST
INDUSTRY REVENUES, 1996-2005*..........................................................................................................68
4.2.2 Total Pharmaceutical Industry: Total Industry Revenue & Profit ...................................................68
Table 4.2 TOTAL PHARMACEUTICALS INSUTRY REVENUE & PROFIT COMPARED,
1996-2005 .......................................................................................................................................................68
4.2.3 Total Pharmaceutical Industry: Regional Output...............................................................................69
Table 4.3 REGIONAL STATISTICS OF CHINA’S PHARMACEUTICALS
MANUFACTURERS, 2003..............................................................................................................................69
4.3 Raw Chemical Medicines Industry..........................................................................................................70
4.3.1 Raw Chemical Medicines Industry: Total Industry Manufacturers & Revenue...........................70
Table 4.4 TOTAL NUMBER OF RAW CHEMICAL MEDICINES MANUFACTURERS
AGAINST INDUSTRY REVENUES, 1996-2005*.....................................................................................70
4.3.2 Raw Chemical Medicines Industry: Total Industry Revenue & Profit ...........................................71
Table 4.5 TOTAL RAW CHEMICAL MEDICINES INSUTRY REVENUE & PROFIT
COMPARED, 1996-2005*................................................................................................................................ 71
4.3.3 Raw Chemical Medicines Industry: Regional Output.......................................................................72
Table 4.6 REGIONAL STATISTICS OF CHINA’S RAW CHEMICAL MEDICINES
MANUFACTURERS, 2003..............................................................................................................................72
4.4 Key Raw Chemical Medicines Manufacturers .....................................................................................73
4.4.1 Key Raw Chemical Medicines Manufacturers: Key Statistics ........................................................73
Table 4.7 SUMMARY STATISTICS OF CHINA’S LEADING RAW CHEMICAL
MEDICINES MANUFACTURERS, 2002....................................................................................................73
Table 4.8 SUMMARY STATISTICS OF CHINA’S LEADING RAW CHEMICAL
MEDICINES MANUFACTURERS, 2003....................................................................................................73
4.4.2 Key Raw Chemical Medicines Manufacturers: Industry Revenue Shares ....................................74

Table 4.9 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’ %
SHARE OF INDUSTRY REVENUES, 2002 ...............................................................................................74
Table 4.10 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’ %
SHARE OF INDUSTRY REVENUES, 2003 ...............................................................................................74
4.4.3 Key Raw Chemical Medicines Manufacturers: Industry Profit Shares..........................................75
Table 4.11 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’ %
SHARE OF INDUSTRY PROFITS, 2002....................................................................................................75
Table 4.12 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’ %
SHARE OF INDUSTRY PROFITS, 2003....................................................................................................75
4.4.4 Key Raw Chemical Medicines Manufacturers: Profitability ...........................................................76
Table 4.13 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’
PROFITABILITY, 2002...................................................................................................................................76
Table 4.14 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’
PROFITABILITY, 2003...................................................................................................................................76
4.4.5 Key Raw Chemical Medicines Manufacturers: Revenue Per Employee.......................................77
Table 4.15 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’
AVERAGE REVENUES PER EMPLOYEE, 2002 ...................................................................................77
Table 4.16 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’
AVERAGE REVENUES PER EMPLOYEE, 2003 ...................................................................................77
4.5 Prepared Chemical (“Western”) Medicines Industry........................................................................78
4.5.1 Prepared Chemical Medicines Industry: Total Industry Manufacturers & Revenue...................78
Table 4.17 TOTAL NUMBER OF PREPARED CHEMICAL MEDICINES
MANUFACTURERS AGAINST INDUSTRY REVENUES, 1996-2005*...........................................78
4.5.2 Prepared Chemical Medicines Industry: Total Industry Revenue & Profit ...................................79
Table 4.18 TOTAL PREPARED CHEMICAL MEDICINES INSUTRY REVENUE &
PROFIT COMPARED, 1996-2005*...............................................................................................................79
4.5.3 Prepared Chemical Medicines Industry: Regional Output...............................................................80
Table 4.19 REGIONAL STATISTICS OF CHINA’S PREPARED CHEMICAL MEDICINES
MANUFACTURERS, 2003..............................................................................................................................80
4.6 Key Prepared Chemical Me dicines Manufacturers ............................................................................81
4.6.1 Key Prepared Chemical Medicines Manufacturers: Key Statistics.................................................81
Table 4.20 SUMMARY STATISTICS OF CHINA’S LEADING PREPARED CHEMICAL
MEDICINES MANUFACTURERS, 2002....................................................................................................81
Table 4.21 SUMMARY STATISTICS OF CHINA’S LEADING PREPARED CHEMICAL
MEDICINES MANUFACTURERS, 2003....................................................................................................81
4.6.2 Key Prepared Chemical Medicines Manufacturers: Industry Revenue Shares.............................82
Table 4.22 CHINA’S LEADING PREPARED CHEMICAL MEDICINES
MANUFACTURERS’ % SHARE OF INDUSTRY REVENUES, 2002..............................................82
Table 4.23 CHINA’S LEADING PREPARED CHEMICAL MEDICINES
MANUFACTURERS’ % SHARE OF INDUSTRY REVENUES, 2003..............................................82
4.6.3 Key Prepared Chemical Medicines Manufacturers: Industry Profit Shares ..................................83

Table 4.24 CHINA’S LEADING PREPARED CHEMICAL MEDICINES
MANUFACTURERS’ % SHARE OF INDUSTRY PROFITS, 2002...................................................83
Table 4.25 CHINA’S LEADING PREPARED CHEMICAL MEDICINES
MANUFACTURERS’ % SHARE OF INDUSTRY PROFITS, 2003...................................................83
4.6.4 Key Prepared Chemical Medicines Manufacturers: Profitability....................................................84
Table 4.26 CHINA’S LEADING PREPARED CHEMICAL MEDICINES
MANUFACTURERS’ PROFITABILITY, 2002 ........................................................................................84
Table 4.27 CHINA’S LEADING PREPARED CHEMICAL MEDICINES
MANUFACTURERS’ PROFITABILITY, 2003 ........................................................................................84
4.6.5 Key Prepared Chemical Medicines Manufacturers: Revenue Per Employee ...............................85
Table 4.28 CHINA’S LEADING PREPARED CHEMICAL MEDICINES
MANUFACTURERS’ AVERAGE REVENUES PER EMPLOYEE, 2002........................................85
Table 4.29 CHINA’S LEADING PREPARED CHEMICAL MEDICINES
MANUFACTURERS’ AVERAGE REVENUES PER EMPLOYEE, 2003........................................85
4.7 Traditional Chinese Medicines Industry................................................................................................86
4.7.1 Traditional Chinese Medicines Industry: Total Industry Manufacturers & Revenue..................86
Table 4.30 TOTAL NUMBER OF TRADITIONAL CHINESE MEDICINES
MANUFACTURERS AGAINST INDUSTRY REVENUES, 1996-2005*...........................................86
4.7.2 Traditional Chinese Medicines Industry: Total Industry Revenue & Profit ..................................87
Table 4.31 TOTAL TRADITIONAL CHINESE MEDICINES INSUTRY REVENUE &
PROFIT COMPARED, 1996-2005*...............................................................................................................87
4.7.3 Traditional Chinese Medicines Industry: Regional Output..............................................................88
Table 4.32 REGIONAL STATISTICS OF CHINA’S TRADITIONAL CHINESE
MEDICINES MANUFACTURERS, 2003....................................................................................................88
4.8 Key Traditional Chinese Medicines Manufacturers ...........................................................................89
4.8.1 Key Traditional Chinese Medicines Manufacturers: Key Statistics ...............................................89
Table 4.33 SUMMARY STATISTICS OF CHINA’S LEADING TRADITIONAL CHINESE
MEDICINES MANUFACTURERS, 2002....................................................................................................89
Table 4.34 SUMMARY STATISTICS OF CHINA’S LEADING TRADITIONAL CHINESE
MEDICINES MANUFACTURERS, 2003....................................................................................................89
4.8.2 Key Traditional Chinese Medicines Manufacturers: Industry Revenue Shares ...........................90
Table 4.35 CHINA’S LEADING TRADITIONAL CHINESE MEDICINES
MANUFACTURERS’ % SHARE OF INDUSTRY REVENUES, 2002..............................................90
Table 4.36 CHINA’S LEADING TRADITIONAL CHINESE MEDICINES
MANUFACTURERS’ % SHARE OF INDUSTRY REVENUES, 2003..............................................90
4.8.3 Key Traditional Chinese Medicines Manufacturers: Industry Profit Shares .................................91
Table 4.37 CHINA’S LEADING TRADITIONAL CHINESE MEDICINES
MANUFACTURERS’ % SHARE OF INDUSTRY PROFITS, 2002...................................................91
Table 4.38 CHINA’S LEADING TRADITIONAL CHINESE MEDICINES
MANUFACTURERS’ % SHARE OF INDUSTRY PROFITS, 2003...................................................91
4.8.4 Key Traditional Chinese Medicines Manufacturers: Profitability ..................................................92

Table 4.39 CHINA’S LEADING TRADITIONAL CHINESE MEDICINES
MANUFACTURERS’ PROFITABILITY, 2002 ........................................................................................92
Table 4.40 CHINA’S LEADING TRADITIONAL CHINESE MEDICINES
MANUFACTURERS’ PROFITABILITY, 2003 ........................................................................................92
4.8.5 Key Traditional Chinese Medicines Manufacturers: Revenue Per Employee ..............................93
Table 4.41 CHINA’S LEADING TRADITIONAL CHINESE MEDICINES
MANUFACTURERS’ AVERAGE REVENUES PER EMPLOYEE, 2002........................................93
Table 4.42 CHINA’S LEADING TRADITIONAL CHINESE MEDICINES
MANUFACTURERS’ AVERAGE REVENUES PER EMPLOYEE, 2003........................................93
4.9 Veterinary Medicines Industry .................................................................................................................94
4.9.1 Veterinary Medicines Industry: Total Industry Manufacturers & Revenue..................................94
Table 4.43 TOTAL NUMBER OF VETERINARY MEDICINES MANUFACTURERS
AGAINST INDUSTRY REVENUES, 1996-2005*.....................................................................................94
4.9.2 Veterinary Medicines Industry: Total Industry Revenue & Profit ..................................................95
Table 4.44 TOTAL VETERINARY MEDICINES INSUTRY REVENUE & PROFIT
COMPARED, 1996-2005*................................................................................................................................ 95
4.9.3 Veterinary Medicines Industry: Regional Output..............................................................................96
Table 4.45 REGIONAL STATISTICS OF CHINA’S VETERINARY MEDICINES
MANUFACTURERS, 2003..............................................................................................................................96
4.10 Key Veterinary Medicines Manufacturers ..........................................................................................97
4.10.1 Key Veterinary Medicines Manufacturers: Key Statistics .............................................................97
Table 4.46 SUMMARY STATISTICS OF CHINA’S LEADING VETERINARY MEDICINES
MANUFACTURERS, 2002..............................................................................................................................97
Table 4.47 SUMMARY STATISTICS OF CHINA’S LEADING VETERINARY MEDICINES
MANUFACTURERS, 2003..............................................................................................................................97
4.10.2 Key Veterinary Medicines Manufacturers: Industry Revenue Shares .........................................98
Table 4.48 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’ %
SHARE OF INDUSTRY REVENUES, 2002 ...............................................................................................98
Table 4.49 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’ %
SHARE OF INDUSTRY REVENUES, 2003 ...............................................................................................98
4.10.3 Key Veterinary Medicines Manufacturers: Industry Profit Shares ...............................................99
Table 4.50 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’ %
SHARE OF INDUSTRY PROFITS, 2002....................................................................................................99
Table 4.51 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’ %
SHARE OF INDUSTRY PROFITS, 2003....................................................................................................99
4.10.4 Key Veterinary Medicines Manufacturers: Profitability ..............................................................100
Table 4.52 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’
PROFITABILITY, 2002.................................................................................................................................100
Table 4.53 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’
PROFITABILITY, 2003.................................................................................................................................100
4.10.5 Key Veterinary Medicines Manufacturers: Revenue Per Employee ..........................................101

Table 4.54 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’
AVERAGE REVENUES PER EMPLOYEE, 2002 .................................................................................101
Table 4.55 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’
AVERAGE REVENUES PER EMPLOYEE, 2003 .................................................................................101
5 SWOT ANALYSIS ..............................................................................................102
5.1 Strengths.......................................................................................................................................................102
5.2 Weaknesses ..................................................................................................................................................102
5.3 Opportunities ..............................................................................................................................................103
5.4 Threats ..........................................................................................................................................................103
6 COMPANY PROFILES......................................................................................104
6.1 Anhui Fengyuan Pharmaceutical Co., Ltd. .........................................................................................104
6.1.1 Anhui Fengyuan Pharmaceutical: Company Details .......................................................................104
6.1.2 Anhui Fengyuan Pharmaceutical: Company Background..............................................................104
6.1.3 Anhui Fengyuan Pharmaceutical: Financial Results .......................................................................104
Table 6.1 ANHUI FENGYUAN PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2003-2005 104
6.2 Astrazeneca (Wuxi) Pharmaceutical Co., Ltd. ...................................................................................105
6.2.1 Astrazeneca (Wuxi) Pharmaceutical: Company Details .................................................................105
6.2.2 Astrazeneca (Wuxi) Pharmaceutical: Financial Results .................................................................105
Table 6.2 ASTRAZENECA (WUXI) PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003 ................................................................................................................................................105
6.3 Bayer AG......................................................................................................................................................106
6.3.1 Bayer: Company Details .......................................................................................................................106
6.3.2 Bayer: Company Background..............................................................................................................106
6.3.3 Bayer: Financial Results.......................................................................................................................107
Table 6.3 BAYER AG.: FINANCIAL RESULTS, 2003-2005.......................................................107
6.4 Beijing Double Crane Pharmaceutical Co., Ltd. ................................................................................108
6.4.1 Beijing Double Crane Pharmaceutical: Company Details ..............................................................108
6.4.2 Beijing Double Crane Pharmaceutical: Company Background.....................................................108
6.4.3 Beijing Double Crane Pharmaceutical: Financial Results..............................................................109
Table 6.4 BEIJING DOUBLE CRANE PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................109
6.5 Beijing SL Pharmaceutical Co., Ltd. .....................................................................................................110
6.5.1 Beijing SL Pharmaceutical: Company Details .................................................................................110
6.5.2 Beijing SL Pharmaceutical: Company Background........................................................................110
6.5.3 Beijing SL Pharmaceutical: Financial Results..................................................................................110
Table 6.5 BEIJING SL PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2003-
2005 .....................................................................................................................................................110

6.6 Beijing Tiantan Biological Products Corp. Ltd. .................................................................................111
6.6.1 Beijing Tiantan Biological Products: Company Details .................................................................111
6.6.2 Beijing Tiantan Biological Products: Company Background........................................................111
6.6.3 Beijing Tiantan Biological Products: Financial Results .................................................................111
Table 6.6 BEIJING TIANTAN BIOLOGICAL PRODUCTS CORP., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................111
6.7 Beijing Tongrentang Co., Ltd..................................................................................................................112
6.7.1 Beijing Tongrentang: Comp any Details ............................................................................................112
6.7.2 Beijing Tongrentang: Company Background...................................................................................112
6.7.3 Beijing Tongrentang: Financial Results.............................................................................................113
Table 6.7 BEIJING TONGRENTANG CO., LTD.: FINANCIAL RESULTS, 2003-2005...113
6.8 Chengdu Hoist Inc. Ltd. ............................................................................................................................114
6.8.1 Chengdu Hoist: Company Details .......................................................................................................114
6.8.2 Chengdu Hoist: Company Background .............................................................................................114
6.8.3 Chengdu Hoist: Financial Results.......................................................................................................114
Table 6.8 CHENGDU HOIST CO., LTD.: FINANCIAL RESULTS, 2003-2005....................114
6.9 Chengzhi Co., Ltd. .....................................................................................................................................115
6.9.1 Chengzhi: Company Details ................................................................................................................115
6.9.2 Chengzhi: Company Background.......................................................................................................115
6.9.3 Chengzhi: Financial Results.................................................................................................................115
Table 6.9 CHENGZHI CO., LTD.: FINANCIAL RESULTS, 2003-2005..................................115
6.10 Chiatai Qingchunbao Pharmaceutical Co., Ltd. ..............................................................................116
6.10.1 Chiatai Qingchunbao Pharmaceutical: Company Details .............................................................116
6.10.2 Chiatai Qingchunbao Pharmaceutical: Financial Results.............................................................116
Table 6.10 CHIATAI QINGCHUNBAO PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2002/2003......................................................................................................................................116
6.11 China National Medicines Corp. Ltd. .................................................................................................117
6.11.1 China National Medicines: Company Details ................................................................................117
6.11.2 China National Medicines: Company Background .......................................................................117
6.11.3 China National Medicines: Financial Results.................................................................................117
Table 6.11 CHINA NATIONAL MEDICINES CO., LTD.: FINANCIAL RESULTS, 2003-
2005 .....................................................................................................................................................117
6.12 Chongqing Huapont Pharmaceutical Co., Ltd. ................................................................................118
6.12.1 Chongqing Huapont Pharmaceutical: Company Details ..............................................................118
6.12.2 Chongqing Huapont Pharmaceutical: Company Background.....................................................118
6.12.3 Chongqing Huapont Pharmaceutical: Financial Results...............................................................118
Table 6.12 CHONGQING HUAPONT PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................118
6.13 Chongqing Taiji Industry (Group) Co., Ltd. ....................................................................................119
6.13.1 Chongqing Taiji Industry Group: Company Details .....................................................................119
6.13.2 Chongqing Taiji Industry Group: Company Background ............................................................119
6.13.3 Chongqing Taiji Industry Group: Financial Results......................................................................119

Table 6.13 CHONGQING TAIJI INDUSTRY GROUP CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................119
6.14 Chongqing Three Gorges Stock Group Co., Ltd. ............................................................................120
6.14.1 Chongqing Three Gorges Stock Group: Company Details ..........................................................120
6.14.2 Chongqing Three Gorges Stock Group: Financial Results ..........................................................120
Table 6.14 CHONGQING THREE GORGES STOCK GROUP CO., LTD.: FINANCIAL
RESULTS, 2003 ................................................................................................................................................120
6.15 Chongqing Tongjunge Co., Ltd. ...........................................................................................................121
6.15.1 Chongqing Tongjunge: Company Details .......................................................................................121
6.15.2 Chongqing Tongjunge: Company Background..............................................................................121
6.15.3 Chongqing Tongjunge: Financial Results .......................................................................................121
Table 6.15 CHONGQING TONGJUNGE CO., LTD.: FINANCIAL RESULTS, 2003-2005121
6.16 Dalian Merro Pharmaceutical Co., Ltd..............................................................................................122
6.16.1 Dalian Merro Pharmaceutical: Company Details ..........................................................................122
6.16.2 Dalian Merro Pharmaceutical: Company Background .................................................................122
6.16.3 Dalian Merro Pharmaceutical: Financial Results...........................................................................122
Table 6.16 DALIAN MERRO PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................122
6.17 Guangdong Kangmei Pharmaceutical Co., Ltd. ..............................................................................123
6.17.1 Guangdong Kangmei Pharmaceutical: Company Details ............................................................123
6.17.2 Guangdong Kangmei Pharmaceutical: Company Background ...................................................123
6.17.3 Guangdong Kangmei Pharmaceutical: Financial Results.............................................................123
Table 6.17 GUANGDONG KANGMEI PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................123
6.18 Guangxi Beisheng Pharmaceutical Co., Ltd. ....................................................................................124
6.18.1 Guangxi Beisheng Pharmaceutical: Company Details ..................................................................124
6.18.2 Guangxi Beisheng Pharmaceutical: Company Background ........................................................124
6.18.3 Guangxi Beisheng Pharmaceutical: Financial Results..................................................................124
Table 6.18 GUANGXI BEISHENG PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................124
6.19 Guangzhou Baiyunshan Pharmaceutical Stock Co., Ltd. ..............................................................125
6.19.1 Guangzhou Baiyunshan Pharmaceutical: Company Details ........................................................125
6.19.2 Guangzhou Baiyunshan Pharmaceutical: Company Background...............................................125
6.19.3 Guangzhou Baiyunshan Pharmaceutical: Financial Results ........................................................125
Table 6.19 GUANGZHOU BAIYUNSHAN PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2004/2005......................................................................................................................................125
6.20 Guangzhou Pharmaceutical Co., Ltd. .................................................................................................126
6.20.1 Guangzhou Pharmaceutical: Company Details ..............................................................................126
6.20.2 Guangzhou Pharmaceutical: Company Background.....................................................................126
6.20.3 Guangzhou Pharmaceutical: Financial Results ..............................................................................126
Table 6.20 GUANGZHOU PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2003-
2005 .....................................................................................................................................................126
6.21 Guilin Jiqi Pharmaceutical Co., Ltd. ..................................................................................................127

6.21.1 Guilin Jiqi Pharmaceutical: Company Details ................................................................................127
6.21.2 Guilin Jiqi Pharmaceutical: Company Background.......................................................................127
6.21.3 Guilin Jiqi Pharmaceutical: Financial Results................................................................................127
Table 6.21 GUILIN JIQI PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2003-
2005 .....................................................................................................................................................127
6.22 Guizhou Yibai Pharmaceutical Co., Ltd. ...........................................................................................128
6.22.1 Guizhou Yibai Pharmaceutical: Company Details ........................................................................128
6.22.2 Guizhou Yibai Pharmaceutical: Company Background...............................................................128
6.22.3 Guizhou Yibai Pharmaceutical: Financial Results.........................................................................128
Table 6.22 GUIZHOU YIBAI PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................128
6.23 Hainan Haiyao Co., Ltd. .........................................................................................................................129
6.23.1 Hainan Haiyao: Company Details ....................................................................................................129
6.23.2 Hainan Haiyao: Company Background...........................................................................................129
6.23.3 Hainan Haiyao: Financial Results.....................................................................................................129
Table 6.23 HAINAN HAIYAO CO., LTD.: FINANCIAL RESULTS, 2003-2005.....................129
6.24 Hangzhou Tianmushan Pharmaceutical Co., Ltd. ..........................................................................130
6.24.1 Hangzhou Tianmushan Pharmaceutical: Company Details .........................................................130
6.24.2 Hangzhou Tianmushan Pharmaceutical: Company Background................................................130
6.24.3 Hangzhou Tianmushan Pharmaceutical: Financial Results .........................................................130
Table 6.24 HANGZHOU TIANMUSHAN PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................130
6.25 Harbin Pharmaceutical Group Holding Co., Ltd. ...........................................................................131
6.25.1 Harbin Pharmaceutical Group: Company Details ..........................................................................131
6.25.2 Harbin Pharmaceutical Group: Company Background.................................................................131
Company History....................................................................................................................................131
Company Key Sectors ............................................................................................................................132
Company Structure.................................................................................................................................132
6.25.3 Harbin Pharmaceutical Group: Financial Results..........................................................................133
Table 6.25 HARBIN PHARMACEUTICAL GROUP CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................133
6.26 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd..............................................134
6.26.1 Harbin Pharmaceutical Group Sanjing Pharmaceutical: Company Details ...............................134
6.26.2 Harbin Pharmaceutical Group Sanjing Pharmaceutical: Company Background .....................134
6.26.3 Harbin Pharmaceutical Group Sanjing Pharmaceutical: Financial Results...............................134
Table 6.26 HARBIN PHARMACEUTICAL GROUP SANJING PHARMACEUTICAL CO.,
LTD.: FINANCIAL RESULTS, 2003-2005................................................................................................134
6.27 Henan Joyline & Joysun Pharmaceutical Co., Ltd. ........................................................................135
6.27.1 Henan Joyline & Joysun Pharmaceutical: Company Details .......................................................135
6.27.2 Henan Joyline & Joysun Pharmaceutical: Company Background..............................................135
6.27.3 Henan Joyline & Joysun Pharmaceutical: Financial Results .......................................................135

Table 6.28 HENAN JOYLINE & JOYS UN PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................135
6.28 Henan Lingrui Pharmaceutical Co., Ltd. ...........................................................................................136
6.28.1 Henan Lingrui Pharmaceutical: Company Details .........................................................................136
6.28.2 Henan Lingrui Pharmaceutical: Company Background ...............................................................136
6.28.3 Henan Lingrui Pharmaceutical: Financial Results.........................................................................136
Table 6.28 HENAN LINGRUI PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................136
6.29 Henan Topfond Pharmaceutical Co., Ltd. .........................................................................................137
6.29.1 Henan Topfond Pharmaceutical: Company Details .......................................................................137
6.29.2 Henan Topfond Pharmaceutical: Company Background .............................................................137
6.29.3 Henan Topfond Pharmaceutical: Financial Results.......................................................................137
Table 6.29 HENAN TOPFOND PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................137
6.30 Hengdian Group Tospo Pharmaceutical Co., Ltd. ..........................................................................138
6.30.1 Hengdian Group Tospo Pharmaceutical: Company Details .........................................................138
6.30.2 Hengdian Group Tospo Pharmaceutical: Financial Results.........................................................138
Table 6.30 HENGDIAN GROUP TOSPO PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................138
6.31 Huadong Medicine Co., Ltd...................................................................................................................139
6.31.1 Huadong Medicine: Company Details .............................................................................................139
6.31.2 Huadong Medicine: Company Background....................................................................................139
6.31.3 Huadong Medicine: Financial Results .............................................................................................139
Table 6.31 HUADONG MEDICINE CO., LTD.: FINANCIAL RESULTS, 2003-2005..........139
6.32 Hualan Biological Engineering Inc. .....................................................................................................140
6.32.1 Hualan Biological Engineering: Company Details ........................................................................140
6.32.2 Hualan Biological Engineering: Company Background...............................................................140
6.32.3 Hualan Biological Engineering: Financial Results........................................................................140
Table 6.32 HUALAN BIOLOGICAL ENGINEERING CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................140
6.33 Hubei Biocause Pharmaceutical Co., Ltd. .........................................................................................141
6.33.1 Hubei Biocause Pharmaceutical: Company Details ......................................................................141
6.33.2 Hubei Biocause Pharmaceutical: Company Background.............................................................141
6.33.3 Hubei Biocause Pharmaceutical: Financial Results.......................................................................141
Table 6.33 HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................141
6.34 Hubei Guangji Pharmaceutical Co., Ltd. ...........................................................................................142
6.34.1 Hubei Guangji Pharmaceutical: Company Details ........................................................................142
6.34.2 Hubei Guangji Pharmaceutical: Company Background...............................................................142
6.34.3 Hubei Guangji Pharmaceutical: Financial Results.........................................................................142
Table 6.34 HUBEI GUANGJI PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................142
6.35 Hubei Qiangjiang Pharmaceutical Co., Ltd. .....................................................................................143

6.35.1 Hubei Qiangjiang Pharmaceutical: Company Details ...................................................................143
6.35.2 Hubei Qiangjiang Pharmaceutical: Company Background..........................................................143
6.35.3 Hubei Qiangjiang Pharmaceutical: Financial Results ...................................................................143
Table 6.35 HUBEI QIANGJIANG PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................143
6.36 Inner Mongolia Biological Pharmaceutical Factory .......................................................................144
6.36.1 Inner Mongolia Biological Pharmaceutical Factory: Company Details ....................................144
6.36.2 Inner Mongolia Biological Pharmaceutical Factory: Financial Results.....................................144
Table 6.36 INNER MONGOLIA BIOLOGICAL PHARMACEUTICAL FACTORY CO.,
LTD.: FINANCIAL RESULTS, 2003-2005................................................................................................144
6.37 Jiangsu Hengrui Medicine Co., Ltd.....................................................................................................145
6.37.1 Jiangsu Hengrui Medicine: Company Details ................................................................................145
6.37.2 Jiangsu Hengrui Medicine: Company Background.......................................................................145
6.37.3 Jiangsu Hengrui Medicine: Financial Results ................................................................................145
Table 6.37 JIANGSU HENGRUI MEDICINE CO., LTD.: FINANCIAL RESULTS, 2003-
2005 .....................................................................................................................................................145
6.38 Jiangsu Kanion Pharmaceutical Co., Ltd. .........................................................................................146
6.38.1 Jiangsu Kanion Pharmaceutical: Company Details .......................................................................146
6.38.2 Jiangsu Kanion Pharmaceutical: Company Background..............................................................146
6.38.3 Jiangsu Kanion Pharmaceutical: Financial Results .......................................................................146
Table 6.38 JIANGSU KANION PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................146
6.39 Jiangsu Lianhuan Pharmaceutical Co., Ltd......................................................................................147
6.39.1 Jiangsu Lianhuan Pharmaceutical: Company Details ...................................................................147
6.39.2 Jiangsu Lianhuan Pharmaceutical: Company Background..........................................................147
6.39.3 Jiangsu Lianhuan Pharmaceutical: Financial Results....................................................................147
Table 6.39 JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................147
6.40 Jiangsu Sihuan Bio-Engineering Co., Ltd. .........................................................................................148
6.40.1 Jiangsu Sihuan Bio-Engineering: Company Details ......................................................................148
6.40.2 Jiangsu Sihuan Bio-Engineering: Company Background ............................................................148
6.40.3 Jiangsu Sihuan Bio-Engineering: Financial Results......................................................................148
Table 6.40 JIANGSU SIHUAN BIO-ENGINEERING CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................148
6.41 Jiangsu Yangzi River Pharmaceutical Group Co............................................................................149
6.41.1 Jiangsu Yangzi River Pharmaceutical Group: Company Details ................................................149
6.41.2 Jiangsu Yangzi River Pharmaceutical Group: Financial Results ................................................149
Table 6.41 JIANGSU YANGZI RIVER PHARMACEUTICAL GROUP CO., LTD.:
FINANCIAL RESULTS, 2003.......................................................................................................................149
6.42 Jiangxi Huiren Group Co., Ltd.............................................................................................................150
6.42.1 Jiangxi Huiren Group: Company Details ........................................................................................150
6.42.2 Jiangxi Huiren Group: Financial Results.........................................................................................150
Table 6.42 JIANGXI HUIREN GROUP CO., LTD.: FINANCIAL RESULTS, 2002/2003...150

6.43 Jiangxi Jiangzhong Pharmaceutical Co., Ltd. ..................................................................................151
6.43.1 Jiangxi Jiangzhong Pharmaceutical: Company Details ................................................................151
6.43.2 Jiangxi Jiangzhong Pharmaceutical: Company Background.......................................................151
6.43.3 Jiangxi Jiangzhong Pharmaceutical: Financial Results.................................................................151
Table 6.43 JIANGXI JIANGZHONG PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................151
6.44 Jilin Aodong Medicine Industry Co., Ltd. .........................................................................................152
6.44.1 Jilin Aodong Medicine Industry: Company Details ......................................................................152
6.44.2 Jilin Aodong Medicine Industry: Company Background.............................................................152
6.44.3 Jilin Aodong Medicine Industry: Financial Results ......................................................................152
Table 6.44 JILIN AODONG MEDICINE Industry CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................152
6.45 Jilin Pharmaceutical Co., Ltd. ..............................................................................................................153
6.45.1 Jilin Pharmaceutical: Company Details ...........................................................................................153
6.45.2 Jilin Pharmaceutical: Company Background..................................................................................153
6.45.3 Jilin Pharmaceutical: Financial Results ...........................................................................................153
Table 6.45 JILIN PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2003-2005..153
6.46 Jilin Xiuzheng Pharmaceutical Group Co., Ltd...............................................................................154
6.46.1 Jilin Xiuzheng Pharmaceutical Group: Company Details ............................................................154
6.46.2 Jilin Xiuzheng Pharmaceutical Group: Financial Results ............................................................154
Table 6.46 JILIN XIUZHENG PHARMACEUTICAL GROUP CO., LTD.: FINANCIAL
RESULTS, 2003 ................................................................................................................................................154
6.47 Ji'nan Guta Veterinary Pharmacy Co., Ltd......................................................................................155
6.47.1 Ji'nan Guta Veterinary Pharmacy: Company Details ....................................................................155
6.47.2 Ji'nan Guta Veterinary Pharmacy: Financial Results ....................................................................155
Table 6.47 JI'NAN GUTA VETERINARY PHARMACY CO., LTD.: FINANCIAL
RESULTS, 2002/2003......................................................................................................................................155
6.48 Jinling Pharmaceutical Co., Ltd...........................................................................................................156
6.48.1 Jinling Pharmaceutical: Company Details ......................................................................................156
6.48.2 Jinling Pharmaceutical: Company Background .............................................................................156
6.48.3 Jinling Pharmaceutical: Financial Results.......................................................................................156
Table 6.48 JINLING PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2003-2005..
.....................................................................................................................................................156
6.49 Jiuzhitang Co., Ltd. .................................................................................................................................157
6.49.1 Jiuzhitang: Company Details .............................................................................................................157
6.49.2 Jiuzhitang: Company Background....................................................................................................157
6.49.3 Jiuzhitang: Financial Results .............................................................................................................157
Table 6.49 JIUZHITANG CO., LTD.: FINANCIAL RESULTS, 2003-2005..............................157
6.50 Joincare Pharmaceutical Industry Gr oup.........................................................................................158
6.50.1 Joincare Pharmaceutical Industry Group: Company Details .......................................................158
6.50.2 Joincare Pharmaceutical Industry Group: Company Background..............................................158
6.50.3 Joincare Pharmaceutical Industry Group: Financial Results........................................................158

Table 6.50 JOINCARE PHARMACEUTICAL INDUSTRY GROUP CO., LTD.:
FINANCIAL RESULTS, 2003-2005.............................................................................................................158
6.51 Kunming Pharmaceutical Corp............................................................................................................159
6.51.1 Kunming Pharmaceutical: Company Details ..................................................................................159
6.51.2 Kunming Pharmaceutical: Company Background.........................................................................159
6.51.3 Kunming Pharmaceutical: Financial Results..................................................................................159
Table 6.51 KUNMING PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2003-
2005 .....................................................................................................................................................159
6.52 Livzon Pharmaceutical Group Co., Ltd. ............................................................................................160
6.52.1 Livzon Pharmaceutical Group: Company Details ..........................................................................160
6.52.2 Livzon Pharmaceutical Group: Company Background ................................................................160
6.52.3 Livzon Pharmaceutical Group: Financial Results..........................................................................161
Table 6.52 LIVZON PHARMACEUTICAL GROUP CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................161
6.53 Nanjing Medical Co., Ltd. ......................................................................................................................162
6.53.1 Nanjing Medical: Company Details .................................................................................................162
6.53.2 Nanjing Medical: Company Background........................................................................................162
6.53.3 Nanjing Medical: Financial Results .................................................................................................162
Table 6.53 NANJING MEDICAL CO., LTD.: FINANCIAL RESULTS, 2003-2005...............162
6.54 Nantong Tiancheng Health Products Co., Ltd. ................................................................................163
6.54.1 Nantong Tiancheng Health Products: Company Details ..............................................................163
6.54.2 Nantong Tiancheng Health Products: Financial Results...............................................................163
Table 6.54 NANTONG TIANCHENG HEALTH PRODUCTS CO., LTD.: FINANCIAL
RESULTS, 2002/2003......................................................................................................................................163
6.55 North China Pharmaceutical Group Corp. .......................................................................................164
6.55.1 North China Pharmaceutical Group: Company Details ................................................................164
6.55.2 North China Pharmaceutical Group: Company Background.......................................................164
Company History....................................................................................................................................164
Core Activities ........................................................................................................................................164
Company Structure.................................................................................................................................165
Key Joint Ventures .................................................................................................................................165
6.55.3 North China Pharmaceutical Group: Financial Results ................................................................168
Table 6.55 NORTH CHINA PHARMACEUTICAL GROUP CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................168
6.56 Northeast Pharmaceutical Group Co., Ltd. ......................................................................................169
6.56.1 Northeast Pharmaceutical Group: Company Details .....................................................................169
6.56.2 Northeast Pharmaceutical Group: Company Background............................................................169
6.56.3 Northeast Pharmaceutical Group: Financial Results .....................................................................169
Table 6.56 NORTHEAST PHARMACEUTICAL GROUP CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................169
6.57 Qilu Pharmaceutical Factory Pingyin Branch..................................................................................170

6.57.1 Qilu Pharmaceutical Factory Pingyin Branch: Company Details ...............................................170
6.57.2 Qilu Pharmaceutical Factory Pingyin Branch: Financial Results ...............................................170
Table 6.57 QILU PHARMACEUTICAL FACTORY PINGYIN BRANCH CO., LTD.:
FINANCIAL RESULTS, 2003.......................................................................................................................170
6.58 Qingdao Groful Pharmaceuticals Co., Ltd. .......................................................................................171
6.58.1 Qingdao Groful Pharmaceuticals : Company Details .....................................................................171
6.58.2 Qingdao Groful Pharmaceuticals : Financial Results.....................................................................171
Table 6.58 QINGDAO GROFUL PHARMACEUTICALS CO., LTD.: FINANCIAL
RESULTS, 2003 ................................................................................................................................................171
6.59 Qingdao Jiante Biological Investment Co., Ltd................................................................................172
6.59.1 Qingdao Jiante Biological Investment: Company Details ............................................................172
6.59.2 Qingdao Jiante Biological Investment: Company Background...................................................172
6.59.3 Qingdao Jiante Biological Investment: Financial Results............................................................172
Table 6.59 QINGDAO JIANTE BIOLOGICAL INVESTMENT CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................172
6.60 Rejoy Group Co., Ltd. .............................................................................................................................173
6.60.1 Rejoy Group: Company Details ........................................................................................................173
6.60.2 Rejoy Group: Financial Results ........................................................................................................173
Table 6.60 REJOY GROUP CO., LTD.: FINANCIAL RESULTS, 2002/2003..........................173
6.61 S&P Pharmaceutical Co., Ltd. ..............................................................................................................174
6.61.1 S&P Pharmaceutical: Company Details ..........................................................................................174
6.61.2 S&P Pharmaceutical: Company Background.................................................................................174
6.61.3 S&P Pharmaceutical: Financial Results ..........................................................................................174
Table 6.61 S&P PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2003-2005....174
6.62 Sanjiu (999) Medical & Pharmaceutical Co., Ltd. ...........................................................................175
6.62.1 Sanjiu Medical & Pharmaceutical: Company Details ...................................................................175
6.62.2 Sanjiu Medical & Pharmaceutical: Company Background..........................................................175
Company History....................................................................................................................................175
Key Sectors..............................................................................................................................................176
Company Structure.................................................................................................................................176
Brand Equity ...........................................................................................................................................176
6.62.3 Sanjiu Medical & Pharmaceutical: Financial Results ...................................................................177
Table 6.62 SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................177
6.63 Shangdong Dong-e E-jiao (Dong'e As-skin) Co., Ltd. ....................................................................178
6.63.1 Shangdong Dong-e E-jiao: Company Details .................................................................................178
6.63.2 Shangdong Dong-e E-jiao: Company Background........................................................................178
6.63.3 Shangdong Dong-e E-jiao: Financial Results.................................................................................178
Table 6.63 SHANGDONG DONG-E E-JIAO CO., LTD.: FINANCIAL RESULTS, 2003-2005.
.....................................................................................................................................................178

6.64 Shandong Liuhe Animal Science Technology Park.........................................................................179
6.64.1 Shandong Liuhe Animal Science Technology Park: Company Details .....................................179
6.64.2 Shandong Liuhe Animal Science Technology Park: Financial Results .....................................179
Table 6.64 SHANDONG LIUHE ANIMAL SCIENCE TECHNOLOGY PARK CO., LTD.:
FINANCIAL RESULTS, 2003.......................................................................................................................179
6.65 Shandong Lukang Pharmaceutical Group Co., Ltd. ......................................................................180
6.65.1 Shandong Lukang Pharmaceutical Group: Company Details ......................................................180
6.65.2 Shandong Lukang Pharmaceutical Group: Company Background ............................................180
6.65.3 Shandong Lukang Pharmaceutical Group: Financial Results......................................................180
Table 6.65 SHANDONG LUKANG PHARMACEUTICAL GROUP CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................180
6.66 Shandong Xinhua Medicine Group Co., Ltd. ...................................................................................181
6.66.1 Shandong Xinhua Medicine Group: Company Details .................................................................181
6.66.2 Shandong Xinhua Medicine Group: Company Background........................................................181
6.66.3 Shandong Xinhua Medicine Group: Financial Results.................................................................181
Table 6.66 SHANDONG XINHUA MEDICINE GROUP CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................181
6.67 Shanghai Asia Pioneer Pharmaceuticals Co., Ltd. ..........................................................................182
6.67.1 Shanghai Asia Pioneer Pharmaceuticals : Company Details ........................................................182
6.67.2 Shanghai Asia Pioneer Pharmaceuticals : Financial Results.........................................................182
Table 6.67 SHANGHAI ASIA PIONEER PHARMACEUTICALS CO., LTD.: FINANCIAL
RESULTS, 2002/2003......................................................................................................................................182
6.68 Shanghai Jiaoda Onlly Co., Ltd............................................................................................................183
6.68.1 Shanghai Jiaoda Onlly: Company Details .......................................................................................183
6.68.2 Shanghai Jiaoda Onlly: Company Background..............................................................................183
6.68.3 Shanghai Jiaoda Onlly: Financial Results .......................................................................................183
Table 6.68 SHANGHAI JIAODA ONLLY CO., LTD.: FINANCIAL RESULTS, 2003-2005183
6.69 Shanghai Leiyunshang Pharmaceutical Co., Ltd. ...........................................................................184
6.69.1 Company: Company Details ..............................................................................................................184
6.69.2 Shanghai Leiyunshang Pharmaceutical: Financial Results ..........................................................184
Table 6.69 SHANGHAI LEIYUNSHANG PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2002/2003......................................................................................................................................184
6.70 Shanghai Modern Pharmaceutical Co., Ltd......................................................................................185
6.70.1 Shanghai Modern Pharmaceutical: Company Details ...................................................................185
6.70.2 Shanghai Modern Pharmaceutical: Company Background..........................................................185
6.70.3 Shanghai Modern Pharmaceutical: Financial Results ...................................................................185
Table 6.70 SHANGHAI MODERN PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................185
6.71 Shanghai Novartis Animal Health Co., Ltd. ......................................................................................186
6.71.1 Shanghai Novartis Animal Health: Company Details ...................................................................186
6.71.2 Shanghai Novartis Animal Health: Financial Results...................................................................186
Table 6.71 SHANGHAI NOVARTIS ANIMAL HEALTH CO., LTD.: FINANCIAL
RESULTS, 2002/2003......................................................................................................................................186

6.72 Shanghai Number 1 Pharmacy Co., Ltd. ...........................................................................................187
6.72.1 Shanghai Number 1 Pharmacy: Company Details .........................................................................187
6.72.2 Shanghai Number 1 Pharmacy: Company Background ...............................................................187
6.72.3 Shanghai Number 1 Pharmacy: Financial Results.........................................................................187
Table 6.72 SHANGHAI NUMBER 1 PHARMACY CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................187
6.73 Shanghai Pharmaceutical Co., Ltd. .....................................................................................................188
6.73.1 Shanghai Pharmaceutical: Company Details ..................................................................................188
6.73.2 Shanghai Pharmaceutical: Company Background.........................................................................188
6.73.3 Shanghai Pharmaceutical: Financial Results ..................................................................................188
Table 6.73 SHANGHAI PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2003-
2005 .....................................................................................................................................................188
6.74 Shanghai Roche Pharmaceutical Co., Ltd. ........................................................................................189
6.74.1 Shanghai Roche Pharmaceutical: Company Details ......................................................................189
6.74.2 Shanghai Roche Pharmaceutical: Financial Results......................................................................189
Table 6.74 SHANGHAI ROCHE PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2002/2003 .....................................................................................................................................................189
6.75 Shanghai Tongren Pharmacy Industry Co., Ltd. ............................................................................190
6.75.1 Shanghai Tongren Pharmacy Industry: Company Details ............................................................190
6.75.2 Shanghai Tongren Pharmacy Industry: Financial Results............................................................190
Table 6.75 SHANGHAI TONGREN PHARMACY INDUSTRY CO., LTD.: FINANCIAL
RESULTS, 2003 ................................................................................................................................................190
6.76 Shanghai Worldbest Pharmaceutical Co., Ltd. ................................................................................191
6.76.1 Shanghai Worldbest Pharmaceutical: Company Details ..............................................................191
6.76.2 Shanghai Worldbest Pharmaceutical: Company Background.....................................................191
6.76.3 Shanghai Worldbest Pharmaceutical: Financial Results...............................................................191
Table 6.76 SHANGHAI WORLDBEST PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................191
6.77 Shanghai Zhongxi Pharmaceutical Co., Ltd. ....................................................................................192
6.77.1 Shanghai Zhongxi Pharmaceutical: Company Details ..................................................................192
6.77.2 Shanghai Zhongxi Pharmaceutical: Company Background.........................................................192
6.77.3 Shanghai Zhongxi Pharmaceutical: Financial Results ..................................................................192
Table 6.77 SHANGHAI ZHONGXI PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................192
6.78 Shanxi Yabao Pharmaceutical Group Co., Ltd................................................................................193
6.78.1 Shanxi Yabao Pharmaceutical Group: Company Details .............................................................193
6.78.2 Shanxi Yabao Pharmaceutical Group: Company Background....................................................193
6.78.3 Shanxi Yabao Pharmaceutical Group: Financial Results .............................................................193
Table 6.78 SHANXI YABAO PHARMACEUTICAL GROUP CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................193
6.79 Shenzhen Accord Pharmaeutical Co., Ltd.........................................................................................194
6.79.1 Shenzhen Accord Pharmaeutical: Company Details .....................................................................194
6.79.2 Shenzhen Accord Pharmaeutical: Company Background............................................................194
6.79.3 Shenzhen Accord Pharmaeutical: Financial Results .....................................................................194

Table 6.79 SHENZHEN ACCORD PHARMAEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................194
6.80 Shijiazhuang Pharmaceutical Group Co., Ltd. ................................................................................195
6.80.1 Shijiazhuang Pharmaceutical Group: Company Details ...............................................................195
6.80.2 Shijiazhuang Pharmaceutical Group: Financial Results ...............................................................195
Table 6.80 SHIJIAZHUANG PHARMACEUTICAL GROUP CO., LTD.: FINANCIAL
RESULTS, 2002/2003......................................................................................................................................195
6.81 Sichuan Baoguang Pharmaceutical Technology Co., Ltd. ............................................................196
6.81.1 Sichuan Baoguang Pharmaceutical Technology: Company Details ...........................................196
6.81.2 Sichuan Baoguang Pharmaceutical Technology: Company Background..................................196
6.81.3 Sichuan Baoguang Pharmaceutical Technology: Financial Results...........................................196
Table 6.81 SICHUAN BAOGUANG PHARMACEUTICAL TECHNOLOGY CO., LTD.:
FINANCIAL RESULTS, 2003-2005.............................................................................................................196
6.82 Sichuan Dikang Pharmaceutical Co., Ltd..........................................................................................197
6.82.1 Sichuan Dikang Pharmaceutical: Company Details ......................................................................197
6.82.2 Sichuan Dikang Pharmaceutical: Company Background.............................................................197
6.82.3 Sichuan Dikang Pharmaceutical: Financial Results ......................................................................197
Table 6.82 SICHUAN DIKANG PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................197
6.83 Sichuan Joint-wit Medica & Pharmaceutical Industry Co., Ltd.................................................198
6.83.1 Sichuan Joint-wit Medica & Pharmaceutical Industry: Company Details ................................198
6.83.2 Sichuan Joint-wit Medica & Pharmaceutical Industry: Company Background.......................198
6.83.3 Sichuan Joint-wit Medica & Pharmaceutical Industry: Financial Results.................................198
Table 6.83 SICHUAN JOINT-WIT MEDICA & PHARMACEUTICAL INDUSTRY CO.,
LTD.: FINANCIAL RESULTS, 2003-2005................................................................................................198
6.84 Sihuan Pharmaceutical Co., Ltd. ..........................................................................................................199
6.84.1 Sihuan Pharmaceutical: Company Details ......................................................................................199
6.84.2 Sihuan Pharmaceutical: Company Background.............................................................................199
6.84.3 Sihuan Pharmaceutical: Financial Results ......................................................................................199
Table 6.84 SIHUAN PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2003-2005...
.....................................................................................................................................................199
6.85 Sino-American Shanghai Squibb Pharmaceutical Co., Ltd..........................................................200
6.85.1 Sino-American Shanghai Squibb Pharmaceutical: Company Details ........................................200
6.85.2 Sino-American Shanghai Squibb Pharmaceutical: Financial Results ........................................200
Table 6.85 SINO-AMERICAN SHANGHAI SQUIBB PHARMACEUTICAL CO., LTD.:
FINANCIAL RESULTS, 2002/2003.............................................................................................................200
6.86 Southwest Pharmaceutical Co., Ltd. ...................................................................................................201
6.86.1 Southwest Pharmaceutical: Company Details ................................................................................201
6.86.2 Southwest Pharmaceutical: Company Background.......................................................................201
6.86.3 Southwest Pharmaceutical: Financia l Results ................................................................................201
Table 6.86 SOUTHWEST PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2003-
2005 .....................................................................................................................................................201
6.87 Taiji Group Fuling Pharmaceutical Factory.....................................................................................202

6.87.1 Taiji Group Fuling Pharmaceutical Factory: Company Details ..................................................202
6.87.2 Taiji Group Fuling Pharmaceutical Factory: Financial Results...................................................202
Table 6.87 TAIJI GROUP FULING PHARMACEUTICAL FACTORY CO., LTD.:
FINANCIAL RESULTS, 2002/2003.............................................................................................................202
6.88 Tianjin Jinyao Group Co., Ltd. ............................................................................................................203
6.88.1 Tianjin Jinyao Group: Company Details .........................................................................................203
6.88.2 Tianjin Jinyao Group: Financial Results .........................................................................................203
Table 6.88 TIANJIN JINYAO GROUP CO., LTD.: FINANCIAL RESULTS, 2002/2003.....203
6.89 Tianjin Pacific Holdings Group Ltd....................................................................................................204
6.89.1 Tianjin Pacific Holdings Group: Company Details .......................................................................204
6.89.2 Tianjin Pacific Holdings Group: Financial Results .......................................................................204
Table 6.89 TIANJIN PACIFIC HOLDINGS GROUP CO., LTD.: FINANCIAL RESULTS,
2002/2003 .....................................................................................................................................................204
6.90 Tianjin Tasly Pharmaceutical Co., Ltd. .............................................................................................205
6.90.1 Tianjin Tasly Pharmaceutical: Company Details ...........................................................................205
6.90.2 Tianjin Tasly Pharmaceutical: Company Background..................................................................205
6.90.3 Tianjin Tasly Pharmaceutical: Financial Results...........................................................................205
Table 6.90 TIANJIN TASLY PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................205
6.91 Tianjin Tianyao Pharmaceutical Co., Ltd. ........................................................................................206
6.91.1 Tianjin Tianyao Pharmaceutical: Company Details ......................................................................206
6.91.2 Tianjin Tianyao Pharmaceutical: Company Background.............................................................206
6.91.3 Tianjin Tianyao Pharmaceutical: Financial Results ......................................................................206
Table 6.91 TIANJIN TIANYAO PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................206
6.92 Tianjin Zhongxin Pharmaceutical Group Co., Ltd.........................................................................207
6.92.1 Tianjin Zhongxin Pharmaceutical: Company Details ...................................................................207
6.92.2 Tianjin Zhongxin Pharmaceutical: Company Background..........................................................207
6.92.3 Tianjin Zhongxin Pharmaceutical: Financial Results....................................................................207
Table 6.92 TIANJIN ZHONGXIN PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................207
6.93 Tibet Rhodiola Pharmaceutical Co., Ltd. ..........................................................................................208
6.93.1 Tibet Rhodiola Pharmaceutical: Company Details ........................................................................208
6.93.2 Tibet Rhodiola Pharmaceutical: Company Background...............................................................208
6.93.3 Tibet Rhodiola Pharmaceutical: Financial Results........................................................................208
Table 6.93 TIBET RHODIOLA PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................208
6.94 Tonghua Dongbao Medicines Co., Ltd. ..............................................................................................209
6.94.1 Tonghua Dongbao Medicines: Company Details ..........................................................................209
6.94.2 Tonghua Dongbao Medicines: Company Background.................................................................209
6.94.3 Tonghua Dongbao Medicines: Financial Results ..........................................................................209
Table 6.94 TONGHUA DONGBAO MEDICINES CO., LTD.: FINANCIAL RESULTS, 2003-
2005 .....................................................................................................................................................209

6.95 Tonghua Goldhorse Medicine Co., Ltd. .............................................................................................210
6.95.1 Tonghua Goldhorse Medicine: Company Details ..........................................................................210
6.95.2 Tonghua Goldhorse Medicine: Company Background.................................................................210
6.95.3 Tonghua Goldhorse Medicine: Financial Results..........................................................................210
Table 6.95 TONGHUA GOLDHORSE MEDICINE CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................210
6.96 Topsun Science & Technology Co., Ltd. ............................................................................................211
6.96.1 Topsun Science & Technology: Company Details ........................................................................211
6.96.2 Topsun Science & Technology: Company Background...............................................................211
6.96.3 Topsun Science & Technology: Financial Results ........................................................................211
Table 6.96 TOPSUN SCIENCE & TECHNOLOGY CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................211
6.97 Tsinghua Unisplendour Guhan Bio-pharmaceutical Co., Ltd. ....................................................212
6.97.1 Tsinghua Unisplendour Guhan Bio-pharmaceutical: Company Details ....................................212
6.97.2 Tsinghua Unisplendour Guhan Bio-pharmaceutical: Company Background...........................212
6.97.3 Tsinghua Unisplendour Guhan Bio-pharmaceutical: Financial Results ....................................212
Table 6.97 TSINGHUA UNISPLENDOUR GUHAN BIO-PHARMACEUTICAL CO., LTD.:
FINANCIAL RESULTS, 2003-2005.............................................................................................................212
6.98 Wuhan Jianmin Pharmaceutical Co., Ltd. ........................................................................................213
6.98.1 Wuhan Jianmin Pharmaceutical: Company Details .......................................................................213
6.98.2 Wuhan Jianmin Pharmaceutical: Company Background .............................................................213
6.98.3 Wuhan Jianmin Pharmaceutical: Financial Results.......................................................................213
Table 6.98 WUHAN JIANMIN PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2003-2005 .....................................................................................................................................................213
6.99 Wuhan Mayinglong Pharmaceutical Co., Ltd. .................................................................................214
6.99.1 Wuhan Mayinglong Pharmaceutical: Company Details ...............................................................214
6.99.2 Wuhan Mayinglong Pharmaceutical: Company Background......................................................214
6.99.3 Wuhan Mayinglong Pharmaceutical: Financial Results ...............................................................214
Table 6.99 WUHAN MAYINGLONG PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................214
6.100 Wuhan Spring Biological Engineering Co., Ltd. ...........................................................................215
6.100.1 Wuhan Spring Biological Engineering: Company Details .........................................................215
6.100.2 Wuhan Spring Biological Engineering: Company Background ...............................................215
6.100.3 Wuhan Spring Biological Engineering: Financial Results.........................................................215
Table 6.100 WUHAN SPRING BIOLOGICAL ENGINEERING CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................215
6.101 Xi'an Janssen Pharmaceutical Co., Ltd. ..........................................................................................216
6.101.1 Xi'an Janssen Pharmaceutical: Company Details ........................................................................216
6.101.2 Xi'an Janssen Pharmaceutical: Financial Results ........................................................................216
Table 6.101 XI'AN JANSSEN PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS,
2002/2003 ................................................................................................................................................216
6.102 Xinle Yuanda Veterinary Pharmaceutical Co., Ltd. ....................................................................217
6.102.1 Xinle Yuanda Veterinary Pharmaceutical: Company Details ...................................................217
6.102.2 Xinle Yuanda Veterinary Pharmaceutical: Financial Results....................................................217

Table 6.102 XINLE YUANDA VETERINARY PHARMACEUTICAL CO., LTD.:
FINANCIAL RESULTS, 2003.......................................................................................................................217
6.103 Yunnan Baiyao Group Co., Ltd. ........................................................................................................218
6.103.1 Yunnan Baiyao Group: Company Details .....................................................................................218
6.103.2 Yunnan Baiyao Group: Company Background ...........................................................................218
6.103.3 Yunnan Baiyao Group: Financial Results.....................................................................................218
Table 6.103 YUNNAN BAIYAO GROUP CO., LTD.: FINANCIAL RESULTS, 2003-2005....
................................................................................................................................................218
6.104 Zhangzhou Pianzihuang Pharmaceutical Co., Ltd. ......................................................................219
6.104.1 Zhangzhou Pianzihuang Pharmaceutical: Company Details .....................................................219
6.104.2 Zhangzhou Pianzihuang Pharmaceutical: Company Background............................................219
6.104.3 Zhangzhou Pianzihuang Pharmaceutical: Financial Results......................................................219
Table 6.104 ZHANGZHOU PIANZIHUANG PHARMACEUTICAL CO., LTD.:
FINANCIAL RESULTS, 2003-2005.............................................................................................................219
6.105 Zhejiang Conba Pharmaceutical Co., Ltd. ......................................................................................220
6.105.1 Zhejiang Conba Pharmaceutical: Company Details ....................................................................220
6.105.2 Zhejiang Conba Pharmaceutical: Company Background...........................................................220
6.105.3 Zhejiang Conba Pharmaceutical: Financial Results ....................................................................220
Table 6.105 ZHEJIANG CONBA PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................220
6.106 Zhejiang Haizheng (Hisun) Group Co., Ltd. ..................................................................................221
6.106.1 Zhejiang Haizheng Group: Company Details ..............................................................................221
6.106.2 Zhejiang Haizheng Group: Company Background .....................................................................221
6.106.3 Zhejiang Haizheng Group: Financial Results...............................................................................221
Table 6.106 ZHEJIANG HAIZHENG GROUP CO., LTD.: FINANCIAL RESULTS, 2003-
2005 ................................................................................................................................................221
6.107 Zhejiang Huahai Pharmaceutical Co., Ltd. ....................................................................................222
6.107.1 Zhejiang Huahai Pharmaceutical: Company Details ...................................................................222
6.107.2 Zhejiang Huahai Pharmaceutical: Company Background .........................................................222
6.107.3 Zhejiang Huahai Pharmaceutical: Financial Results...................................................................222
Table 6.107 ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................222
6.108 Zhejiang International Group Co., Ltd. ...........................................................................................223
6.108.1 Zhejiang International Group: Company Details .........................................................................223
6.108.2 Zhejiang International Group: Company Background................................................................223
6.108.3 Zhejiang International Group: Financial Results.........................................................................223
Table 6.108 ZHEJIANG INTERNATIONAL GROUP CO., LTD.: FINANCIAL RESULTS,
2003-2005 ................................................................................................................................................223
6.109 Zhejiang Jingxin Pharmaceutical Co., Ltd. ....................................................................................224
6.109.1 Zhejiang Jingxin Pharmaceutical: Company Details ..................................................................224
6.109.2 Zhejiang Jingxin Pharmaceutical: Company Background.........................................................224
6.109.3 Zhejiang Jingxin Pharmaceutical: Financia l Results...................................................................224
Table 6.111 ZHEJIANG JINGXIN PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................224
Over-the-counter Pharmaceuticals in China: A Market Analysis
© Access Asia Limited, 2006 Page xxvi
6.110 Zhejiang Medicine Co., Ltd. ................................................................................................................225
6.110.1 Zhejiang Medicine: Company Details ...........................................................................................225
6.110.2 Zhejiang Medicine: Company Background..................................................................................225
6.110.3 Zhejiang Medicine: Financial Results ...........................................................................................225
Table 6.110 ZHEJIANG MEDICINE CO., LTD.: FINANCIAL RESULTS, 2003-2005.....225
6.111 Zhejiang Xinheceng Co., Ltd. .............................................................................................................226
6.111.1 Zhejiang Xinheceng: Company Details .........................................................................................226
6.111.2 Zhejiang Xinheceng: Financial Results.........................................................................................226
Table 6.111 ZHEJIANG XINHECENG CO., LTD.: FINANCIAL RESULTS, 2002/2003.226
6.112 Zhejiang Zhenyuan Co., Ltd. ..............................................................................................................227
6.112.1 Zhejiang Zhenyuan: Company Details ..........................................................................................227
6.112.2 Zhejiang Zhenyuan: Company Background.................................................................................227
6.112.3 Zhejiang Zhenyuan: Financial Results ..........................................................................................227
Table 6.112 ZHEJIANG ZHENYUAN CO., LTD.: FINANCIAL RESULTS, 2003-2005...227
6.113 Zhuzhou Qianjin Pharmaceutical Co., Ltd. ....................................................................................228
6.113.1 Zhuzhou Qianjin Pharmaceutical: Company Details ..................................................................228
6.113.2 Zhuzhou Qianjin Pharmaceutical: Company Background.........................................................228
6.113.3 Zhuzhou Qianjin Pharmaceutical: Financial Results ..................................................................228
Table 6.115 ZHUZHOU QIANJIN PHARMACEUTICAL CO., LTD.: FINANCIAL
RESULTS, 2003-2005......................................................................................................................................228
7 CONTACTS.........................................................................................................229
7.1 Trade Organisations..................................................................................................................................229
7.1.1 China Pharmaceutical Industry Fund.................................................................................................229
7.1.2 China Chemical Pharmaceutical Industry Association...................................................................229
7.2 Government Departments ........................................................................................................................229
7.2.1 State Administration for Traditional Chinese Medicine .................................................................229
7.3 Academic Institutions ...............................................................................................................................230
8 RELEVANT TRADE FAIRS & EXHIBITIONS...............................................231
8.1 Chengdu International Medical Equipment, Health Products, Pharmacy & Packaging Expo ....231
8.2 Fujian Intermed ........................................................................................................................................231
8.3 Northeast China International Medicine & Medical Industry Show................................................231
8.4 Biotech & Pharm Shanghai.....................................................................................................................231
8.5 OTC Pharm China....................................................................................................................................231
8.6 Pharm lngredient China...........................................................................................................................231
8.7 Pharmacy Shanghai..................................................................................................................................232
8.8 The China International Pharmacy & Medical Package Machine Expo .........................................232
8.9 China International Professional Healthcare, Nutrition & Beauty Show........................................232
8.10 Pharmatec China ....................................................................................................................................232
8.11 International Medical Industry & Equipment (Ningbo) Exhibition...............................................232
8.12 Ningbo International Medical & Healthcare Products Show..........................................................232
8.13 Medical, Hospital & Pharmaceutical Trade Fair...............................................................................233
8.14 Tianjin Health Products & Family Health Articles for Use Exhibition.........................................233
8.15 China International Pharmaceutical Industry Exhibition.................................................................233APPENDIX: MARKET BACKGROUND............................................................234
A.1 Fast Facts.....................................................................................................................................................234
A.2 Regions of China .......................................................................................................................................235
Map A.1 CHINA: PROVINCES AND MUNICIPALITIES ........................................................235
A.3 Demographics.............................................................................................................................................237
A.3.1 Demographics: Total Population........................................................................................................237
Table A.1 TOTAL POPULATION, 1997–2004.................................................................................237
A.3.2 Demographics: Population by Location............................................................................................238
Table A.2 POPULATION BY URBAN-RURAL DIVIDE, 1997–2004.......................................238
A.3.3 Demographics: Population Breakdown by Location......................................................................239
Table A.3 POPULATION BREAKDOWN BY URBAN-RURAL DIVIDE, 1997–2004 ........239
A.3.4 Demographics: Population by Province............................................................................................239
Table A.4 POPULATION BY PROVINCE, 2001-2004...................................................................240
A.3.5 Demographics: Population Density by Province.............................................................................240
Table A.5 POPULATION DENSITY BY PROVINCE, 2001-2004..............................................241
A.3.6 Demographics: Population Concentration........................................................................................241
Map A.2 POPULATION CONCENTRATIONS BY PROVINCE, 2004..................................242
A.3.7 Demographics: Population by Gender ..............................................................................................242
Table A.6 TOTAL POPULATION BREAKDOWN BY GENDER, 1997–2004.......................243
A.3.8 Demographics: Population by Age Group........................................................................................243
Table A.7 POPULATION BY AGE GROUP, 1997–2004...............................................................243
Table A.8 % BREAKDOWN OF POPULATION BY AGE GROUP, 1997–2004...................244
A.4 Consumer Attitudes..................................................................................................................................245
A.4.1 Consumer Attitudes: Overview..........................................................................................................245
A.4.2 Consumer Attitudes: Response to Political Change .......................................................................245
A.4.2 Consumer Attitudes: Response to Economic Change....................................................................246
A.4.3 Consumer Attitudes: Changes in Lifestyle .......................................................................................247
Livelihood................................................................................................................................................247
Individual loans.......................................................................................................................................247
Housing....................................................................................................................................................247
Possessions ..............................................................................................................................................248
Travel........................................................................................................................................................248
Entertainment ..........................................................................................................................................249
Health and Fitness ..................................................................................................................................250
Purchasing Influences............................................................................................................................251

Taboos ......................................................................................................................................................251
A.5 Consumer Wealth .....................................................................................................................................252
A.5.1 Consumer Wealth: GDP and Cost of Living....................................................................................252
Dealing with WTO .................................................................................................................................252
China’s New Middle Class....................................................................................................................253
Confident Shoppers................................................................................................................................253
Table A.9 GDP AND COST OF LIVING INDEX, 1997–2004 ......................................................253
A.5.2 Consumer Wealth: Provincial Differences in GDP ........................................................................254
Table 1.10 GDP RANKED BY PROVINCE, 1997–2004..................................................................255
A.5.3 Consumer Wealth: GDP Growth by Province .................................................................................256
Table A.11 GDP GROWTH RANKED BY PROVINCE, 1997–2004............................................256
A.5.4 Consumer Wealth: GDP Per Capita by Province............................................................................257
Table A.12 PER CAPITA GDP RANKED BY PROVINCE, 2001-2004......................................257
A.5.5 Consumer Wealth: Concentration of Wealth by Province.............................................................258
Map A.3 VALUE OF GDP PER CAPITA BY PROVINCE, 2004.............................................258
A.5.6 Consumer Wealth: The Major Cities.................................................................................................259
Table A.13 LEADING CITIES KEY ECONOMIC INDICATORS, 2004...................................259
A.6 Households ..................................................................................................................................................260
A.6.1 Households: Overview of Household Conditions...........................................................................260
A.6.2 Households: Total Households by Size.............................................................................................261
Table A.14 NUMBER OF HOUSEHOLDS BY SIZE, 1997–2004..................................................261
A.6.3 Households: Total households by Urban/Rural Split .....................................................................261
Table A.15 NUMBER AND SIZE OF HOUSEHOLDS BY LOCATION, 1997–2004..............262
A.6.4 Households: Income Earners Per Household...................................................................................262
Table A.16 AVERAGE NUMBER OF INCOME EARNERS PER HOUSEHOLD, 1997–2004..
.....................................................................................................................................................262
A.7 Employment................................................................................................................................................263
A.7.1 Employment: Number of Workers by Sector...................................................................................263
Table A.17 NATIONAL EMPLOYMENT BY SECTOR, 1997–2004...........................................263
A.7.2 Employment: Growth by Sector.........................................................................................................263
Table A.18 GROWTH IN EMPLOYMENT BY SECTOR, 1997–2004........................................264
A.7.3 Employment: Number of Workers by Gender.................................................................................264
Table A.19 TOTAL NATIONAL WORKFORCE BY GENDER, 1997–2004............................264
A.7.3 Employment: Number of Workers by Habitation ...........................................................................265
Table A.20 NATIONAL WORKFORCE BY HABITATION, 1997–2004 ...................................265
A.7.4 Employment: Urban Unemployment ................................................................................................265
Table A.21 URBAN UNEMPLOYMENT RATES, 1997–2004........................................................265
A.8 Consumer Income .....................................................................................................................................267

A.8.1 Consumer Income: Average Incomes by Sector.............................................................................267
Table A.22 AVERAGE INCOMES BY SECTOR, 1997–2004........................................................267
A.8.2 Consumer Income: Growth by Sector...............................................................................................268
Table A.23 GROWTH IN AVERAGE INCOMES BY SECTOR, 1997–2004............................268
A.8.3 Consumer Income: Average Incomes by Region............................................................................269
Table A.24 AVERAGE INCOMES BY REGION, 1997–2004.........................................................269
A.8.4 Consumer Income: Growth by Region..............................................................................................270
Table A.25 GROWTH IN AVERAGE INCOMES BY REGION, 1997–2004.............................270
A.9 Consumer Market.....................................................................................................................................271
A.9.1 Consumer Market: Spending Trends.................................................................................................271
Table A.26 CONSUMER EXPENDITURE* BY BROAD SECTOR AT CURRENT PRICES,
1997–2004* .....................................................................................................................................................271
A.9.2 Consumer Market: Per Capita Consumer Expenditure ..................................................................272
Table A.27 PER CAPITA CONSUMER EXPENDITURE* BY BROAD SECTOR AT
CURRENT PRICES, 1997–2004...................................................................................................................272
A.9.3 Consumer Market: Retail Sales and Consumer Spending.............................................................272
Table A.28 RETAIL SALES AS A PROPORTION OF CONSUMER EXPENDITURE*, 1997–
2004 .....................................................................................................................................................272
A.9.4 Consumer Market: Urban Income and Spending Compared ........................................................273
Table A.29 URBAN AVERAGE ANNUAL INCOME/EXPENDITURE, 1997–2004...............273
A.9.5 Consumer Market: Average Urban Weekly Shopping Basket......................................................274
Chart A.1 AVERAGE WEEKLY URBAN SHOPPING BASKET, 2004...................................274
A.9.6 Consumer Market: Average Rural Weekly Shopping Basket.......................................................275
Chart A.2 AVERAGE WEEKLY RURAL SHOPPING BASKET, 2004...................................275
A.9.7 Consumer Market: Average Urban & Rural Weekly Shopping Baskets Compared.................276
Chart A.3 URBAN & RURAL S HOPPING BASKETS COMPARED, 2004............................276
A.10 Exchange Rates........................................................................................................................................277
A.10.1 Exchange Rates: China......................................................................................................................277
Table A.30 AVERAGE ANNUAL EXCHANGE RATES, 1997–2004...........................................277
A.10.2 Exchange Rates: Hong Kong............................................................................................................277
Table A.31 AVERAGE ANNUAL EXCHANGE RATES, 1997–2004...........................................277

202221.pdf
大小:(2.25 MB)

只需: 100 个论坛币  马上下载


二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝

全部回复
2008-3-31 11:15:00
好贵呀
二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝

2008-10-30 18:13:00
到目前为止,有冤大头买这个吗?
二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝

2008-10-30 21:27:00

二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝

2008-10-30 21:39:00
这个报告都有免费的 名称叫Over-the-counter Pharmaceuticals in China: A Market Analysis
二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝

2014-8-21 00:17:32
。。。。。。。
二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝

点击查看更多内容…
相关推荐
栏目导航
热门文章
推荐文章

说点什么

分享

扫码加好友,拉您进群
各岗位、行业、专业交流群